Haploidentical‐versus identicalsibling transplant for high‐risk pediatric AML: A multicenter study

FM Zheng, X Zhang, CF Li, YF Cheng… - Cancer …, 2020 - Wiley Online Library
… 179 cases of high-risk AML patients under 18 years of age … data of AML patients at first
complete remission (CR1) before … SCT for adult AML patients in their first complete remission (CR1…

… haploidentical versus HLA-matched sibling allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a retrospective study on …

G Battipaglia, A Boumendil, M Labopin… - … marrow transplantation, 2019 - nature.com
… with acute myeloid leukemia (AML), in nearly 10–40% of cases complete remission (CR) is
not … -PTCY and Haplo-ATG with HLA-identical sibling recipients, we observed that the inferior …

[HTML][HTML] … stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission …

D Salvatore, M Labopin, A Ruggeri, G Battipaglia… - …, 2018 - ncbi.nlm.nih.gov
acute myeloid leukemia (AML). However, a human leukocyte antigen (HLA)-identical sibling
2 … In a recent prospective multicenter non-randomized study from China, Wang et al. showed …

… graft-versus-leukemia effect than HLA-matched sibling transplantation for high-risk acute myeloid leukemia in first complete remission: a prospective multicentre …

S Yu, F Huang, Y Wang, Y Xu, T Yang, Z Fan, R Lin… - Leukemia, 2020 - nature.com
… -leukemia (GVL) of haploidentical donor (HID) compared with … acute myeloid leukemia
(H-AML) in first complete remission (… H-AML in CR1 were enrolled in this multicentre prospective

… -identical donor transplantation compared with identical sibling donor had better anti-leukemia effect for refractory/relapsed acute myeloid leukemia not in remission …

Y Lu, YL Zhao, JP Zhang, M Xiong, XY Cao, DY Liu… - Annals of …, 2020 - Springer
… with high-risk features, haplo-identical-hematopoietic stem cell transplantation (HID-HSCT) …
an identical sibling donor (ISD-HSCT). However, it is unclear whether an HID-HSC transplant

… between haplo identical stem cell transplantation and matched sibling donor stem cell transplantation for high-risk acute myeloid leukemia in first complete remission

Y Liu, X Huang, Q Fei, L Xu, X Zhang, K Liu… - Science China Life …, 2019 - Springer
… outcome of patients with acute myeloid leukemia in remission after haploidentical
Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study. …

Stem cell transplantation from a haploidentical donor versus a genoidentical sister for adult male patients with acute myelogenous leukemia in first remission: a …

NC Gorin, M Labopin, D Blaise, M de Groot, G Socié… - Cancer, 2020 - Wiley Online Library
… This study was a retrospective, multicenter analysis. Data were provided by the EBMT … an
option for those without a matched identical sibling. The use of nongenoidentical family donors …

Haploidentical transplant for myelodysplastic syndrome: registry-based comparison with identical sibling transplant

Y Wang, HX Wang, YR Lai, ZM Sun, DP Wu, M Jiang… - Leukemia, 2016 - nature.com
… Recently, our institute reported the results of HSCT from haploidentical donors (HIDs) in 36
Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective

Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from …

A Nagler, M Labopin, M Houhou, M Aljurf… - Journal of Hematology & …, 2021 - Springer
… In patients lacking an HLA-identical sibling donor the next … This was a retrospective,
multicenter analysis using the … with ALL in the first or second complete remission (CR1 or CR2, …

[HTML][HTML] Haploidentical and Matched Sibling Transplantation for Acute Myeloid Leukemia: A Hospital-Based Study

JC Baena, MC Rosales, M Estacio, A Hidalgo… - Journal of …, 2023 - ncbi.nlm.nih.gov
… and intermediate risk AML in first complete remission (CR1) [3]… donors other than an
HLA-identical sibling donor [48], studies … Future research should be considered multicenter design …